Trials / Completed
CompletedNCT01692951
Serum Free Fatty Acid Metabolite Biomarkers of Lung Cancer
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 220 (actual)
- Sponsor
- The Cleveland Clinic · Academic / Other
- Sex
- All
- Age
- 40 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
This study aims to evaluate the performance of serum free fatty acids as biomarkers for the identification of lung cancer.
Detailed description
We will compare the concentration of free fatty acids and their metabolites between patients with lung cancer and control pulmonary patients without known cancer. The diagnostic accuracy will be assessed for potential predictors.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | serum sample | Serum samples from lung cancer patients were collected at the time of their diagnosis, prior to the initiation of treatment. Serum samples of control subjects were collected from a biobank |
Timeline
- Start date
- 2012-08-01
- Primary completion
- 2014-09-01
- Completion
- 2014-09-01
- First posted
- 2012-09-26
- Last updated
- 2017-06-20
- Results posted
- 2017-06-20
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01692951. Inclusion in this directory is not an endorsement.